CAI insider transaction filings

Caris Life Sciences, Inc. — 47 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-14. Screen CAI transaction legs live →

FiledFormInsiderReported transactionsSource
2026-08-144PHILLIPS T DANNY — DirectorGrant/award (A): 13,192 @ $0EDGAR
2026-08-144CASTLEMAN PETER M — DirectorGrant/award (A): 13,192 @ $0EDGAR
2026-08-144Fredrickson David Paul — DirectorGrant/award (A): 13,192 @ $0EDGAR
2026-08-144Gilliam Joseph E — DirectorGrant/award (A): 13,192 @ $0EDGAR
2026-08-144Minor Lloyd — DirectorGrant/award (A): 13,192 @ $0EDGAR
2026-08-144HALBERT JON — DirectorGrant/award (A): 13,192 @ $0EDGAR
2026-08-144JOHANSEN LAURA I — DirectorGrant/award (A): 13,192 @ $0EDGAR
2026-08-144Vacirca Jeff L — DirectorGrant/award (A): 13,192 @ $0EDGAR
2026-07-134HALBERT JON — DirectorPurchase (P): 68,000 @ $14.56EDGAR
2026-06-024Knowles Jonathan Kenneth Charles — DirectorGrant/award (A): 1,600 @ $15.62EDGAR
2026-06-024POSTE GEORGE — DirectorGrant/award (A): 1,600 @ $15.62EDGAR
2026-05-184Power Luke Thomas — See RemarksTax withholding (F): 9,771 @ $15.25EDGAR
2026-05-184Brille Brian J — See Remarks, DirectorTax withholding (F): 13,987 @ $15.25EDGAR
2026-05-184Spetzler David Baxley — PresidentTax withholding (F): 13,856 @ $15.25EDGAR
2026-05-184Denton John Russel — See RemarksTax withholding (F): 6,047 @ $15.25EDGAR
2026-05-184HALBERT DAVID D — See Remarks, Director, 10% ownerTax withholding (F): 40,712 @ $15.25EDGAR
2026-05-124Vacirca Jeff L — DirectorPurchase (P): 31,050 @ $16.15EDGAR
2026-03-104Power Luke Thomas — See RemarksGrant/award (A): 63,971 @ $0EDGAR
2026-03-104Brille Brian J — See Remarks, DirectorGrant/award (A): 83,162 @ $0EDGAR
2026-03-104Spetzler David Baxley — PresidentGrant/award (A): 83,162 @ $0EDGAR
2026-03-104Denton John Russel — See RemarksGrant/award (A): 63,971 @ $0EDGAR
2026-03-104HALBERT DAVID D — See Remarks, Director, 10% ownerGrant/award (A): 320,112 @ $0EDGAR
2026-03-024Minor Lloyd — DirectorGrant/award (A): 2,492 @ $20.06EDGAR
2026-02-274Fredrickson David Paul — DirectorGrant/award (A): 2,492 @ $20.06EDGAR
2026-02-274Vacirca Jeff L — DirectorGrant/award (A): 2,492 @ $20.06EDGAR
2026-02-274PHILLIPS T DANNY — DirectorGrant/award (A): 3,739 @ $20.06EDGAR
2026-02-274CASTLEMAN PETER M — DirectorGrant/award (A): 5,509 @ $20.06EDGAR
2026-02-274HALBERT JON — DirectorGrant/award (A): 2,492 @ $20.06EDGAR
2026-01-134CASTLEMAN PETER M — DirectorOption exercise (M): 2,500 @ $18.60 · Option exercise (M): 2,500 (derivative) @ $0EDGAR
2025-12-124Power Luke Thomas — See RemarksOption exercise (M): 24,750 @ $2.44 · Option exercise (M): 37,500 @ $2.44 · Sale (S): 60,850 @ $26.56 · Sale (S): 1,400 @ $27.16 · Option exercise (M): 24,750 (derivative) @ $0 · Option exercise (M): 37,500 (derivative) @ $0EDGAR
2025-12-124Brille Brian J — See Remarks, DirectorGift (G): 650 @ $0 · Gift (G): 650 @ $0EDGAR
2025-11-104Spetzler David Baxley — PresidentPurchase (P): 400 @ $23.85EDGAR
2025-11-104Denton John Russel — See RemarksPurchase (P): 4,184 @ $24.09EDGAR
2025-09-124PHILLIPS T DANNY — DirectorOption exercise (M): 100,000 @ $2.44 · Option exercise (M): 100,000 (derivative) @ $0EDGAR
2025-08-134Spetzler David Baxley — PresidentTax withholding (F): 63,509 @ $29.75EDGAR
2025-08-134POSTE GEORGE — DirectorOption exercise (M): 125,000 @ $2.44 · Tax withholding (F): 48,022 @ $29.75 · Tax withholding (F): 91,495 @ $29.75 · Option exercise (M): 125,000 (derivative) @ $0EDGAR
2025-08-134HALBERT DAVID D — See Remarks, Director, 10% ownerTax withholding (F): 141,956 @ $29.75EDGAR
2025-06-234Spetzler David Baxley — PresidentDisposition to issuer (D): 700,509 @ $18.60 · Grant/award (A): 132,428 @ $0 · Option exercise (M): 75,000 @ $2.44 · Tax withholding (F): 34,782 @ $27.25 · Grant/award (A): 750,000 (derivative) @ $0 · Option exercise (M): 75,000 (derivative) @ $0EDGAR
2025-06-234Power Luke Thomas — See RemarksGrant/award (A): 99,321 @ $0EDGAR
2025-06-234Denton John Russel — See RemarksDisposition to issuer (D): 238,230 @ $18.60 · Grant/award (A): 99,321 @ $0 · Purchase (P): 7,500 @ $21 · Grant/award (A): 255,000 (derivative) @ $0EDGAR
2025-06-234ADAPT I Ltd. — 10% owner
Carisome I, L.P. — 10% owner
Conversion (C): 3,500,003 @ $0 · Conversion (C): 14,000,000 (derivative)EDGAR
2025-06-234Brille Brian J — See Remarks, DirectorGrant/award (A): 132,428 @ $0 · Purchase (P): 30,000 @ $21EDGAR
2025-06-234TSSP Sub-Fund HoldCo LLC
Waxman Alan
Conversion (C): 1,721,015 · Conversion (C): 3,881,988 · Conversion (C): 3,493,789 · Conversion (C): 478,779 · Conversion (C): 531,746 · Conversion (C): 10,103,175 · +14 moreEDGAR
2025-06-234J H Whitney VI L P — 10% owner
J. H. Whitney Equity Partners VI, LLC — 10% owner
VIGANO PAUL R — 10% owner
WILLIAMS ROBERT M JR — 10% owner
Conversion (C): 12,516,834 · Conversion (C): 50,067,334 (derivative) @ $0EDGAR
2025-06-234CASTLEMAN PETER M — DirectorGrant/award (A): 16,129 @ $0 · Conversion (C): 10,245,906 @ $0 · Grant/award (A): 2,500 (derivative) @ $0 · Conversion (C): 40,983,607 (derivative)EDGAR
2025-06-234HALBERT JON — DirectorGrant/award (A): 16,129 @ $0 · Conversion (C): 1,250,000 @ $0 · Conversion (C): 5,000,000 (derivative)EDGAR
2025-06-234HALBERT DAVID D — See Remarks, Director, 10% owner
Caris Halbert, L.P. — Director, 10% owner
Grant/award (A): 360,750 @ $0 · Grant/award (A): 413,839 @ $0 · Conversion (C): 104,761,535 @ $0 · Conversion (C): 389,416,484 (derivative) · Conversion (C): 29,629,630 (derivative)EDGAR

Recent 8-K events — Caris Life Sciences, Inc.

FiledFormItems reportedSource
2026-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-058-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-028-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
EDGAR
2026-02-268-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-128-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-308-K3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-06-208-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CAI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →